Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CLF vs MRNA✓SelectedUSD · MRNACLF vs MRNA performance historyLatest closeAs of-4.43%11/16
Stock and ETF performance explorer

CLF vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-43.7%
MRNA return
-8.0%
Excess return
-35.7%
Maximum drawdown
-82.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.4%-3.6%-0.8%-4.2%
7D-1.4%-20.0%+18.6%-0.2%
30D-0.2%-1.3%+1.0%-0.3%
3M+1.6%+240.0%-238.4%-9.0%
6M+17.3%+339.0%-321.7%-1.2%
YTD-9.0%+630.0%-638.9%-31.9%
1Y+12.7%+769.1%-756.4%-18.9%
3Y-29.0%+181.2%-210.3%-42.8%
5Y-43.7%-8.1%-35.5%-49.8%
All-43.7%-8.0%-35.7%-49.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling